Protalix BioTherapeutics, Inc. has filed 943 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| SC 13G | 2026-07-29 | Beneficial Ownership Report (Passive) |
| 8-K | 2026-06-25 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits |
| 8-K | 2026-05-21 | Regulation FD Disclosure; Financial Statements and Exhibits |
| 8-K | 2026-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits |
| 10-Q | 2026-05-13 | Quarterly Report |
| DEF 14A | 2026-04-30 | Proxy Statement |
| SCHEDULE 13G/A | 2026-03-30 | SCHEDULE 13G/A |
| 8-K | 2026-03-18 | Results of Operations and Financial Condition; Financial Statements and Exhibits |
| 10-K | 2026-03-18 | Annual Report |
| 8-K | 2026-03-09 | Other Events; Financial Statements and Exhibits |